Anonymous (PDMR)

CEO

Insider activity · 24 months3 buys0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 1 buy · 0 salesJun 26 · 2 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (3 ops.)

€29k

▼ Sales (0 ops.)

—

Latest filing published 29 Jul 2026 for Laboratorio Farmaceutico Erfo. Read the official filing

Filing timeline

BuySale

Anonymous (PDMR)

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Anonymous (PDMR): trading record in brief

Anonymous (PDMR) appears in our data through filings on Laboratorio Farmaceutico Erfo shares, published by Consob. We count 5 filings; the first trade dates from 25 May 2026 and the latest from 27 July 2026.

The open-market record is one-sided, with 3 purchases worth €29k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants.

A typical purchase (the median) is worth €8,840. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 29 July 2026, reports a share grant in Laboratorio Farmaceutico Erfo. The last insider purchase was made public on 7 June 2026, 132 days ago. Filings reach the Consob feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Consob. They describe what insiders did and are not a recommendation.